» Authors » Antoine Thierry

Antoine Thierry

Explore the profile of Antoine Thierry including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 779
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertrand D, Chavarot N, Olagne J, Greze C, Gatault P, Danthu C, et al.
Transpl Int . 2024 Dec; 37:13544. PMID: 39712083
After kidney transplantation, conversion to belatacept is a promising alternative in patients with poor graft function or intolerance to calcineurin inhibitors. The risk of acute rejection has not been well...
2.
Villeneuve C, Rerolle J, Couzi L, Westeel P, Etienne I, Esposito L, et al.
Transplant Direct . 2024 Jul; 10(8):e1678. PMID: 39076520
Background: In kidney transplant recipients with positive serology (R+) for the cytomegalovirus (CMV), 2 strategies are used to prevent infection, whose respective advantages over the other are still debated. This...
3.
Bertrand D, Gatault P, Jaureguy M, Garrouste C, Duveau A, Bouvier N, et al.
Transplantation . 2024 Jul; 108(8):e204-e206. PMID: 39042372
No abstract available.
4.
Garrouste C, Freist M, Prezelin-Reydit M, Bouquegneau A, Fournier T, Schvartz B, et al.
Nephrol Ther . 2024 Jun; 20(3):193-202. PMID: 38920047
The management of patients with kidney transplant failure (KTF) remains a complex process involving multiple stakeholders. A working group of the Transplantation Commission of the French-speaking Society of Nephrology, Dialysis...
5.
Savoye E, Martin-Lefevre L, Dantal J, Dorez D, Gaudez F, Drouin S, et al.
Transplantation . 2024 Jun; 108(12):e417-e427. PMID: 38872246
Background: This study examined 1071 adult primary kidney transplants from the French-controlled donation after the circulatory determination of death (cDCD) program, which uses normothermic regional perfusion (NRP), and involves short...
6.
Uro-Coste C, Lambert C, Audard V, Couzi L, Caillard S, Buchler M, et al.
Nephrol Dial Transplant . 2024 May; 40(3):475-483. PMID: 38794882
Background: Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation and is classically associated with a significant decrease in graft survival. A major risk factor is a prior...
7.
Villeneuve C, Humeau A, Monchaud C, Labriffe M, Rerolle J, Couzi L, et al.
Clin Pharmacol Ther . 2024 Feb; 116(2):351-362. PMID: 38372185
The clinical impact of individual dose adjustment of mycophenolate mofetil is still debated, due to conflicting results from randomized clinical trials. This retrospective study aimed to compare 3-year rejection-free survival...
8.
Noelle J, Mayet V, Lambert C, Couzi L, Chauveau B, Thierry A, et al.
Transpl Int . 2023 Oct; 36:11775. PMID: 37799669
The impact of immunosuppressive therapy (IS) strategies after kidney transplant failure (KTF) on potential future new grafts is poorly established. We assessed the potential benefit of calcineurin inhibitor (CNI)-based IS...
9.
Monchaud C, Woillard J, Crepin S, Tafzi N, Micallef L, Rerolle J, et al.
Transpl Int . 2023 Aug; 36:11366. PMID: 37588007
LCP-tacrolimus displays enhanced oral bioavailability compared to immediate-release (IR-) tacrolimus. The ENVARSWITCH study aimed to compare tacrolimus AUC in stable kidney (KTR) and liver transplant recipients (LTR) on IR-tacrolimus converted...
10.
Couzi L, Malvezzi P, Amrouche L, Anglicheau D, Blancho G, Caillard S, et al.
Transpl Int . 2023 Jul; 36:11244. PMID: 37448448
Imlifidase recently received early access authorization for highly sensitized adult kidney transplant candidates with a positive crossmatch against an ABO-compatible deceased donor. These French consensus guidelines have been generated by...